Nowadays, the attention of
nanoparticle-bearing bacteria as drug carrier is increasing with decreasing
side effects in the treatment of cancer. Nanoparticles have better release and
selectivity with less toxicity .Due to the cost-effectiveness of using bacteria
and the conditions for the growth of drug delivery with nanoscale particles
that is less in size and less toxic, it has been the goal of drug delivery. Targeted
drug delivery with nano carriers is possible to control the location, timing,
and speed of drug release. Anaerobic gram-negative bacteria such as Salmonella
and E. coli and also beneficial intestinal bacteria, including bacterial
Bifidium. have been used in the treatment of cancer that are in clinical trials
of laboratory studies. In this review article, we are trying to draw up new
related patterns that provide effective ways for research and future
achievements by reviewing novel bacteria-targeted drug delivery methods.
No comments:
Post a Comment